General Newsletter
Issue
633
ICER: Top Unsupported Drug Price Hikes in 2021; NHS Begins Digital Home Health Check Trial; ALZ-NET Real-World Data Network Launches
Published Dec. 13, 2022
Jobs Newsletter
Issue
307
Our HEOR Jobs Roundup is back!
Published Dec. 10, 2022
General Newsletter
Issue
632
No Word from FDA on Orphan Drug Exclusivity; DARWIN EU RWE Studies Begin; Cost and Safety Concerns Float over New Alzheimer's Drug
Published Dec. 6, 2022
Sponsored Newsletter
ISPOR Europe HEOR Theater presentations now online
Published Dec. 1, 2022
Sponsored Newsletter
NEXT WEEK | Designing Causal Inference Studies Using Real-World Data
Published Nov. 30, 2022
General Newsletter
Issue
631
ICER to Assess Sickle Cell Therapy; EU Launches ONCOVALUE RWD AI Initiative; FDA Approves Most Expensive Therapy Yet
Published Nov. 29, 2022
General Newsletter
Issue
630
Eli Lilly to Pull Twitter Advertising after Fake Insulin Tweet; The State of Market Access in Denmark; Leadiant Faces Fines in Spain
Published Nov. 22, 2022
Sponsored Newsletter
Exclusive Whitepaper: Rare disease and real-world data: How RWD can help deliver better therapies and better outcomes
Published Nov. 21, 2022
Sponsored Newsletter
How to approach value-based care and precision medicine using RWD
Published Nov. 17, 2022
General Newsletter
Issue
629
US Democrats Eye High Drug Launch Prices; The State of US Healthcare with a Split Congress; WHO Releases Telemedicine Guide
Published Nov. 15, 2022
Sponsored Newsletter
THURSDAY | Streamlining Health Technology Assessments by Automating Literature Reviews
Published Nov. 14, 2022
Sponsored Newsletter
Live webinar on December 7th, sign up today!
Published Nov. 9, 2022
General Newsletter
Issue
628
India's Pharma Industry Strong Amid Inflation; ICER Revises Hemophilia Gene Therapy Report; FDA Discusses Pulse Oximeter Innaccuracies
Published Nov. 8, 2022
General Newsletter
Issue
626
Pfizer Eyes 400% Price Hike for COVID-19 Vaccine; FDA Opens PDUFA Applications; HHS Takes 340B Loss
Published Oct. 25, 2022
Sponsored Newsletter
NEXT WEEK | Achieving Consensus When Everyone is an Expert, but No One Agrees
Published Oct. 17, 2022
Sponsored Newsletter
Lumanity's Expanded Patient-Centered Outcomes Capabilities
Published Oct. 14, 2022
Sponsored Newsletter
REGISTER | Accelerating the Generation of Payer Insights and Evidence Across the Product Lifecycle to Achieve Optimal Access
Published Oct. 13, 2022
General Newsletter
Issue
624
Medicare Advantage Turnover Higher than Reported, US FTC Pulls the Stops on PBM Investigation; 1,200 Drug Prices Outstripped Inflation
Published Oct. 11, 2022
